Sarah L. Davies

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Hyperresponsive B Cells in CD22-Deficient Mice

Theresa L. O’Keefe, Gareth T. Williams, Sarah L. Davies et al. · Science · 1996 · 528 citations

Autoimmune Disease, Adaptive Immune System, Hyperresponsive B Cells +13

Endomysial antibody: is it the best screening test for coeliac disease?

Mariana Simões Larraz Ferreira, Sarah L. Davies, M. Butler et al. · Gut · 1992 · 254 citations · Full text

Immunology, Gastroenterology, Diagnosis +20

Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response

Michael R. Ehrenstein, Theresa L. O’Keefe, Sarah L. Davies et al. · Proceedings of the National Academy of Sciences · 1998 · 222 citations · Full text